From Casetext: Smarter Legal Research

The Peter Ballantyne Cree Nation v. Purdue Pharma (In re Purdue Pharma Bankr. Appeals)

United States District Court, S.D. New York
Oct 29, 2021
21 cv 7962 (CM) (S.D.N.Y. Oct. 29, 2021)

Opinion

21 cv 7962 (CM)

10-29-2021

In re PURDUE PHARMA BANKRUPTCY APPEALS v. Purdue Pharma, et al. This Filing Relates to The Peter Ballantyne Cree Nation, et al.


NOTICE

MCMAHON, J.

Question addressed to counsel for the Canadian Appellants: is there a misplaced “not” at the end of the fourth line from the bottom of page 24 of your brief? Should not that sentence read: “Accordingly, whenever the Shareholder Released Patties took actions to control multiple Purdue entities, which is what they usually did, claims based on that conduct are not subject to the carve out and are released?” Please advise soonest.


Summaries of

The Peter Ballantyne Cree Nation v. Purdue Pharma (In re Purdue Pharma Bankr. Appeals)

United States District Court, S.D. New York
Oct 29, 2021
21 cv 7962 (CM) (S.D.N.Y. Oct. 29, 2021)
Case details for

The Peter Ballantyne Cree Nation v. Purdue Pharma (In re Purdue Pharma Bankr. Appeals)

Case Details

Full title:In re PURDUE PHARMA BANKRUPTCY APPEALS v. Purdue Pharma, et al. This…

Court:United States District Court, S.D. New York

Date published: Oct 29, 2021

Citations

21 cv 7962 (CM) (S.D.N.Y. Oct. 29, 2021)